CSL Receives Official Warning From FDA
Australia’s largest biotech, CSL, last week received an official warning from the US Food and Drug Administration listing concerns relating to the company’s manufacture of its influenza vaccine, Afluria, at its Parkville, Victoria, plant.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.